Paper prepared by academics for NERVTAG on viral evasion during antibody treatment of the new SARS-CoV 2 immunity-escape variants. It was considered at SAGE 75 on 7 January 2021.
The paper is the assessment of the evidence at the time of writing. As new evidence or data emerges, SAGE updates its advice accordingly.
This paper is a technical briefing which details how the new SARS-CoV-2 variant may react to antibody and immunisation treatment.
See more information on the new SARS-CoV-2 variant.
These documents are released as pre-print publications that have provided the government with rapid evidence during an emergency. These documents have not been peer-reviewed and there is no restriction on authors submitting and publishing this evidence in peer-reviewed journals.